新検索ページはこちら
ログイン
お問い合わせ
（旧版）前立腺癌診療ガイドライン 2006年版
書誌情報
第2章 診断
参考文献
| 1） | Chodak GW: Early detection and screening for prostatic cancer. Urology. 1989;34:10-2. |
| 2） | Pedersen KV, Carlsson P, Varenhorst E, et al. Screening for carcinoma of the prostate by digital rectal examination in a randomly selected population. BMJ. 1990;300:1041-4. |
| 3） | Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen（PSA）in the early detection of prostate cancer:results of a multicenter clinical trial of 6630 men. J Urol. 1994;151:1283-90. |
| 4） | Haas GP, Monyie JE, Pontes JE. The state of prostate cancer screening in the United States. Eur Urol. 1993;23:337-47. |
| 5） | Gretzer MB, Partin AW:PSA markers in prostate cancer detection. Urol Clin North Am. 2003;30（4）:677-86. |
| 6） | Okihara K, Cheli CD, Partin AW, et al. Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer. J Urol. 2002;167:2017-23. |
| 7） | Elgamal AA, van Poppel HP, van de Voorde WM, et al. Impalpable, invisible stage T1c prostate cancer:characteristics and clinical relevance in 100 radical prostatectomy specimens--a different view. J Urol. 1997;157:244-50. |
| 8） | Gustafsson O, Norming U, Almgard LE, et al. Diagnostic methods in the detection of prostate cancer:a study of a randomly selected population of 2,400 men. J Urol. 1992;148:1827-31. |
| 9） | Mettlin C, Murphy GP, Babaian RJ, et al. The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer. 1996;77:150-9. |
| 10） | Punglia RS, D’Amico AV, Catalona WJ, et al. Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. N Engl J Med. 2003;349（4）:335-42. |
| 11） | Hodge KK, McNeal JE, Terris MK et al. Random systemamic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol. 1989;142:71-4. |
| 12） | Emiliozzi P, Corsetti A, Tassi B, et al. Best approach for prostate cancer detection:a prospective study on transperineal versus transrectal six-core prostate biopsy. Urology. 2003;61（5）:961-6. |
| 13） | Emiliozzi P, Longhi S, Scarpone P, et al. The value of a single biopsy with 12 transperineal cores for detecting prostate cancer in patients with elevated prostate specific antigen. J Urol. 2001;166（3）:845-50. |
| 14） | Raaijmakers R, Kirkels WJ, Roobol MJ, et al. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology. 2002;60（5）:826-30. |
| 15） | Babaian RJ, Toi A, Kamoi K, et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol 2000;163（1）;152-7. |
| 16） | Presti JC Jr, Chang JJ, Bhargava V et al. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies:result of a prospective clinical trial. J Urol. 2000;163（1）:163-6;discussion 166-7. |
| 17） | Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen lvalues. J Urol. 1994;151:1571-4. |
| 18） | Roerhborn CG, Pickers GJ, Sanders JS. Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnosis and prostate specific antigen levels. Urology 1996;47:347-52. |
| 19） | Zlotta AR, Raviv G, Schulman CC. Clinical prognostic criteria for later diagnosis of prostate carcinoma in patients with initial isolated prostatic intraepithelial neoplasia. Eur Urol. 1996;30（2）:249-55. |
| 20） | Haggman MJ, Macoska JA, Wojno KJ, et al. The relationship between prostatic intraepithelial neoplasia and prostate cancer:critical issues. J Urol. 1997;158（1）:12-22. |
| 21） | Spigelman SS, McNeal JE, Freiha FS, et al. Rectal examination in volume determination of carcinoma of the prostate:clinical and anatomical correlations. J Urol. 1986;136:1228-30. |
| 22） | Partin AW, Mangold LA, Lamm DM, et al. Contemporary update of prostate cancer staging nomograms（Partin Tables）for the new millennium. Urology, 2001;58:843-8. |
| 23） | Rorvik J, Halvorsen OJ, Servoll E, et al. Transrectal ultrasonography to assess local extent of prostatic cancer before radical prostatectomy. Br J Urol. 1994 73:65-9. |
| 24） | Lee N, Newhouse JH, Olsson CA, et al. Which patients with newly diagnosed prostate cancer need a computed tomography scan of the abdomen and pelvis? An analysis based on 588 patients. Urology 1999;54:490-4. |
| 25） | Jager GJ, Severens JL, Thornbury JR, et al:Prostate cancer staging:should MR imaging be used?--A decision analytic approach. Radiology. 2000;215:445-51. |
| 26） | Heenan SD. Magnetic resonance imaging in prostate cancer. Prostate Cancer Prostatic Dis. 2004;7:282-8. |
| 27） | Partin AW, Yoo J, Carter HB, et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol. 1993;150:110-4. |
| 28） | Whitmore WF Jr:Natural history and staging of prostate cancer. Urol Clin North Am. 1984;11:205-20. |
| 29） | Gerber G, Chodak GW. Assessment of value of routine bone scans in patients with newly diagnosed prostate cancer. Urology. 1991;37:418-22. |
| 30） | Soloway MS, Hardeman SW, Hickey D, et al. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer. 1988;61:195-202. |
| 31） | Rana A, Karamanis K, Lucas MG, et al. Identification of metastatic disease by T category, gleason score and serum PSA level in patients with carcinoma of the prostate. Br J Urol. 1992;69:277-81. |
| 32） | Oesterling JE. Prostate specific antigen:a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol. 1991;145:907-23. |
| 33） | Oesterling JE. Using PSA to eliminate the staging radionuclide bone scan. Significant economic implications. Urol Clin North Am. 1993;20:705-11. |
